https://www.prnewswire.com/news-releases/correvio-highlights-fda-acceptance-of-united-therapeutics-trevyent-new-drug-application-300916707.html
Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
/PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today...
united therapeuticsnew drughighlightsfdaacceptance